Lawrence Boise

Active 1993–2025

106
Papers
27,641
Citations
77
h-index
103
i10-index

Citations

Citations per year for Lawrence Boise1982: 1 citations1983: 1 citations1985: 1 citations1986: 1 citations1989: 1 citations1990: 1 citations1992: 1 citations1993: 14 citations1994: 78 citations1995: 216 citations1996: 400 citations1997: 456 citations1998: 468 citations1999: 376 citations2000: 355 citations2001: 283 citations2002: 257 citations2003: 257 citations2004: 216 citations2005: 176 citations2006: 149 citations2007: 143 citations2008: 145 citations2009: 126 citations2010: 123 citations2011: 172 citations2012: 201 citations2013: 248 citations2014: 335 citations2015: 328 citations2016: 251 citations2017: 219 citations2018: 177 citations2019: 629 citations2020: 754 citations2021: 802 citations2022: 612 citations2023: 385 citations2024: 642 citations2025: 269 citations2026: 7 citations1984: no citations, so this year is not shown1987–1988: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,140 citing papers, 33.7% of this breakdownChina: 1,428 citing papers, 11.6% of this breakdownUnited Kingdom: 647 citing papers, 5.3% of this breakdownGermany: 616 citing papers, 5% of this breakdownItaly: 474 citing papers, 3.8% of this breakdownFrance: 465 citing papers, 3.8% of this breakdownCanada: 428 citing papers, 3.5% of this breakdownJapan: 392 citing papers, 3.2% of this breakdownAustralia: 322 citing papers, 2.6% of this breakdownSpain: 265 citing papers, 2.1% of this breakdownNetherlands: 219 citing papers, 1.8% of this breakdownSouth Korea: 206 citing papers, 1.7% of this breakdown
0%33.7%Other 21.9%

Fields

  • Medicine41.2%
  • Biochemistry, Genetics and Molecular Biology40.8%
  • Immunology and Microbiology8.7%
  • Neuroscience2%
  • Computer Science1.4%
  • Agricultural and Biological Sciences1.2%
  • Other4.7%

Topics

  • Cell death mechanisms and regulation6.2%
  • Autophagy in Disease and Therapy6%
  • Multiple Myeloma Research and Treatments3.3%
  • Immune Cell Function and Interaction2.6%
  • Protein Degradation and Inhibitors2.4%
  • Ubiquitin and proteasome pathways2.3%
  • Other77.2%

Coauthors

All papers

Open in search
  1. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis

    Authors: , , , , - BMC Cell Biology 2013 cited by 1,273

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David K. Ann, Shailendra Anoopkumar‐Dukie, Hiroshi Aoki, Nadezda Apostolova, Giuseppe Arancia, John P. Aris, Katsuhiko Asanuma, Nana Asare, Hisashi Ashida, Valerie Askanas, David S. Askew, Patrick Auberger, Misuzu Baba, Steven K. Backues, Eric H. Baehrecke, Ben A. Bahr, Xue-Yuan Bai, Yannick Bailly, Robert A. Baiocchi, Giulia Baldini, Walter Balduini, Andrea Ballabio, Bruce A. Bamber, Edward T. W. Bampton, Gábor Juhász, Clinton R. Bartholomew, Diane C. Bassham, Robert C. Bast, Henri Batoko, Boon-Huat Bay, Isabelle Beau, Daniel M. Béchet, Thomas J. Begley, Christian Behl, Christian Behrends, Soumeya Bekri, Bryan H. Bellaire, Linda J. Bendall, Luca Benetti, Laura Berliocchi, Henri Bernardi, Francesca Bernassola, Sébastien Besteiro, Ingrid Bhatia-Kissova, Xiaoning Bi, Martine Biard-Piechaczyk, Janice S. Blum, Lawrence Boise, Paolo Bonaldo, David L. Boone, Beat Bornhäuser, Karina Ramalho Bortoluci, Ioannis Bossis, Frédéric Bost, Jean‐Pierre Bourquin, Patricia Boya, Michaël Boyer‐Guittaut, Peter V. Bozhkov, Nathan Brady, Claudio Brancolini, Andreas Brech, Jay E. Brenman, Ana Brennand, Emery Bresnick, Patrick Brest, Dave Bridges, Molly L. Bristol, Paul S. Brookes, Eric J. Brown, John H. Brumell and 1,170 more - Autophagy 2012 cited by 4,046

  3. Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edwin Clark, David M. Wilson, Stephen E. Fawell, Alexander W. Hird - Nature Communications 2018 cited by 486

  4. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

    Authors: , , , , , - Blood 2006 cited by 1,148

  5. Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joan Levy, Daniel Auclair, Jonathan D. Licht, Jonathan J. Keats, Lawrence Boise, Benjamin L. Ebert, James E. Bradner, Nathanael S. Gray, Constantine S. Mitsiades - Cell Reports 2021 cited by 115

  6. Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy

    Authors: , , , , , , , , , , , , , , , - JCI Insight 2019 cited by 168

  7. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 161

  8. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

    Authors: , , , , , , , , - Cell 1993 cited by 3,116

  9. Salmonella-induced cell death: apoptosis, necrosis or programmed cell death?

    Authors: , - Trends in Microbiology 2001 cited by 176

  10. Cancer Metabolism and the Evasion of Apoptotic Cell Death

    Authors: , , - Cancers 2019 cited by 185

  11. Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

    Authors: , , , , , , , , , , , , , , , - Blood Cancer Journal 2019 cited by 165

  12. Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2023 cited by 47

  13. Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

    Authors: , , , , , , , , , , , , , - Nature Communications 2019 cited by 157

  14. The prodomain of caspase-3 regulates its own removal and caspase activation

    Authors: , - Cell Death Discovery 2019 cited by 138

  15. Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 237

  16. Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2017 cited by 168

  17. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 103

  18. Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma

    Authors: , , , - Frontiers in Immunology 2019 cited by 158

  19. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard W.J. Groen, Nathanael S. Gray, Aedín C. Culhane, James M. McFarland, Joshua M. Dempster, Jonathan D. Licht, Lawrence Boise, William C. Hahn, Francisca Vázquez, Aviad Tsherniak, Constantine S. Mitsiades - Nature Cancer 2023 cited by 40

  20. MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 155

  21. Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression

    Authors: , , , , , , , , , , , , , , , - Blood 2021 cited by 81

  22. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL

    Authors: , , , , , , - Immunity 1995 cited by 1,206

  23. Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion

    Authors: , , , , , , , , , , , , , , - Nature Communications 2017 cited by 129

  24. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death

    Authors: , , , , , - Cell 1995 cited by 2,124